Peripheral glia and neurons jointly regulate activity-induced synaptic remodeling at the Drosophila neuromuscular junction

  1. Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, United States
  2. Dept. of Physiology & Neuroscience, Keck School of Medicine, University of Southern California, Los Angeles, United States

Peer review process

Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, and public reviews.

Read more about eLife’s peer review process.

Editors

  • Reviewing Editor
    Margaret Ho
    National Yang Ming Chiao Tung University, Taipei, Taiwan
  • Senior Editor
    Lu Chen
    Stanford University, Stanford, United States of America

Reviewer #1 (Public review):

In this manuscript, Chang et al. investigated the cell type-specific role of the integrin activator Shv in activity-dependent synaptic remodeling. Using the Drosophila larval neuromuscular junction as a model, they show that glial-secreted Shv modulates synaptic plasticity by maintaining the extracellular balance of neuronal Shv proteins and regulating ambient extracellular glutamate concentrations, which in turn affects postsynaptic glutamate receptor abundance. Furthermore, they report that genetic perturbation of glial morphogenesis phenocopies the defects observed with the loss of glial Shv. Altogether, their findings propose a role for glia in activity-induced synaptic remodeling through Shv secretion. While the conclusions are intriguing, several issues related to experimental design and data interpretation merit further discussion.

Reviewer #2 (Public review):

In this paper Chang et al follow up on their lab's previous findings about the secreted protein Shv and its role in activity-induced synaptic remodeling at the fly NMJ. Previously they reported that shv mutants have impaired synaptic plasticity. Normally a high stimulation paradigm should increase bouton size and GluR expression at synapses but this does not happen in shv mutants. The phenotypes relating to activity dependent plasticity were completely recapitulated when Shv was knocked down only in neurons and could be completely rescued by incubation in exogenously applied Shv protein. The authors also showed that Shv activation of integrin signaling on both the pre- and post- synapse was the molecular mechanism underlying its function. Here they extend their study to consider the role of Shv derived from glia in modulating synaptic features at baseline and remodeling conditions. This study is important to understand if and how glia contribute to these processes. Using cell-type specific knockdown of Shv only in glia causes abnormally high baseline GluR expression and prevents activity-dependent increases in bouton size or GluR expression post-stimulation. This does not appear to be a developmental defect as the authors show that knocking down Shv in glia after basic development has the same effects as life long knockdown, so Shv is acting in real time. Restoring Shv in ONLY glia in mutant animals is sufficient to completely rescue the plasticity phenotypes and baseline GluR expression, but glial-Shv does not appear to activate integrin signaling which was shown to be the mechanism for neuronally derived Shv to control plasticity. This led the authors to hypothesize that glial Shv works by controlling the levels of neuronal Shv and extracellular glutamate. They provide evidence that in the absence of glial Shv, synaptic levels of Shv go up overall, presumably indicating that neurons secrete more Shv. In this context which could then work via integrin signaling as described to control plasticity. They use a glutamate sensor and observe decreased signal (extracellular glutamate) from the sensor in glial Shv KD animals, however, this background has extremely high GluR levels at the synapse which may account for some or all of the decreases in sensor signal in this background. Additional controls to test if increased GluR density alone affects sensor readouts and/or independently modulating GluR levels in the glial KD background would help strengthen this data. In fact, glial-specific shv KD animals have baseline levels of GluR that are potentially high enough to have hit a ceiling of expression or detection that accounts for the inability for these levels to modulate any higher after strong stimulation and such a ceiling effect should be considered when interpreting the data and conclusions of this paper. Several outstanding questions remain-why can't glial derived Shv activate integrin pathways but exogenously applied recombinant Shv protein can? The effects of neuronal specific rescue of shv in a shv mutant are not provided vis-à-vis GluR levels and bouton size to compare to the glial only rescue. Inclusion of this data might provide more insight to outstanding questions of how and why the source of Shv seems to matter for some aspects of the phenotypes but not others despite the fact that exogenous Shv can rescue and in some experimental paradigms but not others.

Reviewer #3 (Public review):

Summary:

The manuscript by Chang and colleagues provides compelling evidence that glia-derived Shriveled (Shv) modulates activity-dependent synaptic plasticity at the Drosophila neuromuscular junction (NMJ). This mechanism differs from the previously reported function of neuronally released Shv, which activates integrin signaling. They further show that this requirement of Shv is acute and that glial Shv supports synaptic plasticity by modulating neuronal Shv release and the ambient glutamate levels. However, there are a number of conceptual and technical issues that need to be addressed.

Major comments

(1) From the images provided for Fig 2B +RU486, the bouton size appears to be bigger in shv RNAi + stimulation, especially judging from the outline of GluR clusters.
(2) The shv result needs to be replicated with a separate RNAi.
(3) The phenotype of shv mutant resembles that of neuronal shv RNAi - no increased GluR baseline. Any insights why that is the case?
(4) In Fig 3B, SPG shv RNAi has elevated GluR baseline, while PG shv RNAi has a lower baseline. In both cases, there is no activity induced GluR increase. What could explain the different phenotypes?
(5) In Fig 4C, the rescue of PTP is only partial. Does that suggest neuronal shv is also needed to fully rescue the deficit of PTP in shv mutants?
(6) The observation in Fig 5D is interesting. While there is a reduction in Shv release from glia after stimulation, it is unclear what the mechanism could be. Is there a change in glial shv transcription, translation or the releasing machinery? It will be helpful to look at the full shv pool vs the released ones.
(7) In Fig 5E, what will happen after stimulation? Will the elevated glial Shv after neuronal shv RNAi be retained in the glia?
(8) It would be interesting to see if the localization of shv differs based on if it is released by neuron or glia, which might be able to explain the difference in GluR baseline. For example, by using glia-Gal4>UAS-shv-HA and neuronal-QF>QUAS-shv-FLAG. It seems important to determine if they mix together after release? It is unclear if the two shv pools are processed differently.
(9) Alternatively, do neurons and glia express and release different Shv isoforms, which would bind different receptors?
(10) It is claimed that Sup Fig 2 shows no observable change in gross glial morphology, further bolstering support that glial Shv does not activate integrin. This seems quite an overinterpretation. There is only one image for each condition without quantification. It is hard to judge if glia, which is labeled by GFP (presumably by UAS-eGFP?), is altered or not.
(11) The hypothesis that glutamate regulates GluR level as a homeostatic mechanism makes sense. What is the explanation of the increased bouton size in the control after glutamate application in Fig 6?
(12) What could be a mechanism that prevents elevated glial released Shv to activate integrin signaling after neuronal shv RNAi, as seen in Fig 5E?
(13) Any speculation on how the released Shv pool is sensed?

  1. Howard Hughes Medical Institute
  2. Wellcome Trust
  3. Max-Planck-Gesellschaft
  4. Knut and Alice Wallenberg Foundation